Item 2.02. Results of Operations and Financial Condition. OnMarch 2, 2020 ,Neon Therapeutics, Inc. (the "Company") issued a press release announcing its financial results for the quarter and year endedDecember 31, 2019 . A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information contained in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing. Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release issued by the Company onMarch 2, 2020 , furnished herewith 2
--------------------------------------------------------------------------------
© Edgar Online, source